INTRODUCTION
Arsenic is a chemical that evokes many images, most of which are negative. Inorganic arsenic is a common constituent of the earth's crust in its pentavalent form, and is widely distributed in soil and water. Humans may encounter inorganic arsenic in drinking water from wells drilled into arsenic-rich strata. Overt arsenic poisoning has occurred in some countries of Asia and the Americas through the consumption of contaminated well water or foods. Epidemiological studies have provided evidence that inorganic arsenic is a human carcinogen. Also, it is well known that inorganic arsenic has a strong acute toxicity in humans and experimental animals. 1) An alternative approach to studies of the mechanism of arsenic carcinogenesis and toxicity has used cultured mammalian cells, and the findings obtained from cell culture studies have directly linked the exposure to inorganic arsenic to processes fundamental to carcinogenesis, however, there has been little information about the detailed evaluation and the mechanisms of the toxic effects of methylated arsenics which are metabolites of inorganic arsenic in mammals ( Fig. 1) . In humans and most experimental animals, pentavalent inorganic arsenate is rapidly reduced to trivalent arsenite, and then they are methylated as the principal metabolic reaction. In vivo studies suggest that methylated pentavalent arsenics, monomethylarsonic acid (MMAs V ) and dimethylarsinic acid (DMAs V ), have been identified as or- Inorganic arsenic is clearly a toxicant and carcinogen in humans. In mammals, including humans, inorganic arsenic often undergo methylation, forming compounds such as pentavalent dimethyarsinic acid (DMAs V ). Recent evidence indicates that DMAs V is a complete carcinogen in rodents while evidence for inorganic arsenic as a carcinogen in rodents remains unclear. Thus, we studied the molecular mechanisms of the in vitro cytolethality of DMAs V compared to that of the trivalent inorganic arsenic, sodium arsenite, using rat liver TRL 1215 cells. Arsenite was very cytotoxic in these cells; its lethal concentration in vitro in 50% of a population (LC 50 ) was 20 µM after a 48-hr exposure. With arsenite, most dead cells showed histological and biochemical evidence of necrosis. The arsenite cytolethality markedly increased when cellular reduced glutathione (GSH) was depleted with the glutathione synthase inhibitor, L-buthionine-[S,R]-sulfoximine (BSO). In contrast, DMAs V was nearly three orders of magnitude less cytotoxic (LC 50 = 1.5 mM) although evidence showed the predominating form of death was apoptosis. Surprisingly, GSH depletion actually decreased the DMAs V -induced apoptosis. It is suggested that DMAs V requires intracellular GSH to induce apoptosis. Ethacrynic acid (EA), an inhibitor of glutathione S-transferase that catalyzes GSHsubstrate conjugation, and aminooxyacetic acid (AOAA), an inhibitor of β-lyase which catalyzes the final breakdown of GSH-substrate conjugates, were also effective in suppressing the DMAs V -induced apoptosis. These findings indicate that DMAs V was likely conjugated in some form with cellular GSH, and this conjugate induced apoptosis during subsequent metabolic reactions. Because apoptosis is a process by which organisms eliminate abnormal cells, the arsenic biomethylation in the human body may essentially a detoxicating event.
ganic metabolites in human urine after the administration of inorganic arsenic in either the trivalent or pentavalent state. 2, 3) DMAs V is the ultimate metabolite in humans, 3) while the DMAs V is further methylated to pentavalent trimethylarsine oxide (TMAs V O) in some rodents (Fig. 1) .
2) It is believed that the methylation of inorganic arsenic results in the lowering of their general toxicity as indicated by their increased lethal dose in vivo 4) and in vitro, 5, 6) but recent studies increasingly suggest that the methylation of inorganic arsenic is not a universal detoxification mechanism. It has been reported that DMAs V could significantly act as tumor promoters in rodents both in vivo 7) and in vitro, [8] [9] [10] however, further details on the toxic effects of DMAs V have not been reported. Thus, defining the mechanisms of chronic arsenic poisoning and carcinogenesis requires further studies on the toxicity of DMAs V , the ultimate arsenic metabolite in humans, because inorganic arsenic is methylated and accumulated in arsenic poisoning patients. 11) In this review, it is reported that our recent studies about the in vitro cytolethality of DMAs V compared with that of inorganic arsenite using TRL 1215 cells 12, 13) which were derived from rat liver that is a major tissue for the metabolism of inorganic arsenic and is also a target tissue for their carcinogenic effects. We found that inorganic arsenite has a strong cytolethality; it induced necrosis in the cells at µM levels. In contrast, DMAs V was not cytotoxic at µM levels but it completely induced apoptosis at mM levels. Also, interestingly, DMAs V required intracellular reduced glutathione (GSH) to induce apoptosis, and this is quite different from inorganic arsenite and MMAs V for which GSH generally reduces the cytolethality. Apoptosis is a process by which organisms eliminate the abnormal cells, thus, the biomethylation of inorganic arsenic in the human body may essentially be a detoxicating event.
DMAs V Requires Cellular GSH to Induce Apoptosis

12)
The TRL 1215 cell line is a rat normally nontumorigenic epitherial liver cell line originally derived from the liver of 10-day old Fisher F344 rats. 14) Inorganic sodium arsenite was strongly cytotoxic in TRL 1215 cells; it's lethal concentration in vitro in 50% of a population (LC 50 ) after a 48-hr exposure was 20 µM (Fig. 2) , and it primarily induced necrotic cell death indicated by the cellular morphological changes, nuclear terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL) staining and changes in the cell surface annexin-V expressions. 15) In contrast, MMAs V did not show any potent in vitro cytolethality even over 10 mM (Fig. 2) . DMAs V showed weak but significant cytolethality in TRL 1215 cells; its LC 50 was 1.5 mM which was much higher than that of inorganic arsenite (Fig. 2) . Interestingly, DMAs V completely induced apoptosis at mM levels as indicated by the cellular morphological changes, condensed nuclei, nuclear TUNEL staining, changes in the cell surface annexin-V expressions and internucleosomal DNA fragmentation. We also previously reported similar results using mouse resident macrophages.
5) The reasons why DMAs V selectively induced apoptosis in mammal cells have not yet been precisely clarified. We demonstrated that intracellular GSH played key roles in inducing apoptosis by DMAs V . In the case of inorganic arsenite, the depletion of cellular GSH with a GSH synthase inhibitor, L-buthionie-[S,R]-sulfoximine (BSO), significantly enhanced its cytolethality. MMAs V also became cytotoxic at mM levels when cellular GSH was depleted although it had no cytolethality in the presence of cellular GSH (Fig. 2) . Cellular GSH must play an important role in protecting against the cytolethality of arsenite and MMAs V depending on both the chelation of these arsenic compounds and the scavenging of active oxygen produced by arsenite or MMAs V stimulation. This hypothesis was supported by results that the addition of exogenous GSH completely abolished the cytolethality of arsenite in TRL 1215 cells in the presence or absence of cellular GSH (Table 1) . Conversely, BSO significantly prevented DMAs V -induced apoptosis in a dose dependent manner (Fig. 2) . The additions of other kinds of cellular GSH-deplet- ing agents, such as diethyl maleate (a GSH scavenger) and carmustine (a glutathione reductase inhibitor), also significantly inhibited the DMAs V -induced apoptosis in TRL 1215 cells. These findings suggest that DMAs V might selectively induce apoptosis that was related to the cellular GSH status. Styblo et al. and Zakharyan et al. previously described that cellular GSH was a critical cofactor for the promotion of the in vitro enzymatic methylation of arsenite and MMAs V . 16, 17) Thus, we tried to clarify if the ability to methylate arsenic was related to the role of cellular GSH in the DMAs V cytolethality using the chimpanzee skin CRL-1609 cell line because chimpanzee cells have no arsenic methyl transferase activities.
18) The treatment with BSO significantly decreased the cytolethality of DMAs V in the chimpanzee CRL-1609 cells like that used in the rat liver TRL 1215 cells that have potent arsenic methyl transferases (unpublished data). It is likely that the ability to methylate arsenic appears to have little to do with the role of GSH in the DMAs V toxicity. In that study, we showed an interesting hypothesis that the conjugation of DMAs V and intracellular GSH might be an important event in the induction of apoptosis by DMAs V treatment (Fig. 3) . When cellular GSH synthesis was stopped by BSO-treatment, the addition of DMAs V further decreased the cellular GSH levels compared with those of cells treated by BSO alone (unpublished data), and the BSO treatment slightly but significantly increased the cellular uptake of DMAs V in the TRL 1215 cells (Table 2) . However, the addition of BSO actually increased cell survival after the DMAs V as described above. These data suggest that DMAs V by itself was not highly cytotoxic but it became cytotoxic and selectively induced apoptosis when it was conjugated with intracellular GSH (Fig. 3) . This suggestion was supported by results that the addition of ethacrynic acid (EA), an inhibitor of glutathione S-transferase which catalyzes GSH-substrate conjugation, significantly inhibited the DMAs V -induced apoptosis in TRL 1215 cells. We also demonstrated that the addition of acivicin, an inhibitor of γ-glutamyltranspeptidase which catalyzes the initial breakdown of the GSH-substrate conjugates, and aminooxyacetic acid (AOAA), an inhibitor of β-lyase which catalyzes the final breakdown of the GSH-substrate conjugates, significantly inhibited the DMAs V -induced apoptosis. The combination of these GSHsubstrate metabolic enzyme inhibitors and BSO showed a significant additive-like preventive effect on the DMAs V -induced apoptosis. These data imply that DMAs V made a conjugate with the intracellular GSH, and this became cytotoxic during the subsequent metabolic reaction of the GSH-DMA conjugates in the cells (Fig. 3) . In contrast, the treatment of EA significantly enhanced the cytolethality of inorganic arsenite in the TRL 1215 cells, although AOAA had no effect on it. Also, exogenous GSH completely prevented the arsenite-induced necrosis regardless of the presence of BSO as described above (Table 1) . Therefore, the binding of GSH to arsenite might simply inhibit the cytolethality of arsenite. The addition of 5,5-dimethyl-1-pyrroline N-oxide (DMPO), a potent cell membrane permeable radi- a) TRL cells were pre-incubated with BSO (25 µM) for 24-hr, and continuously incubated with DMA (1 mM) for an additional 24-hr in the presence or absence of BSO and/or GSH (250 µM), and then, the amounts of arsenic contained in cell lysates were measured by atomic absorption spectophotpmetry. Results are expressed as mean ± SEM (n = 3). *p < 0.001, in comparison to cells incubated with DMAs V only. cal trap reagent, strongly inhibited the DMAs V -induced apoptosis in TRL 1215 cells, and a marked additive-like effect was observed upon inhibition of the DMAs V -induced apoptosis by the combination of DMPO and BSO or inhibitors against the GSHsubstrate metabolic enzymes. These data indicate that DMAs V caused the production of certain kinds of free radicals in the TRL 1215 cells, and these free radicals might play a key role in inducing the subsequent apoptosis (Fig. 3) . Our preliminary results, using electron spin resonance spectroscopy and DMPO as a radical trapping reagent, indicated that an as yet unidentified radical species is formed by the DMAs V treatment in these cells, and current efforts are directed toward identification of this radical species. The most potent inhibitors of the DMAs V -induced apoptosis did not affect the cellular uptake of the DMAs V in TRL 1215 cells. This result indicates that the significant preventive effects of these reagents on DMAs V cytolethality probably do not depend on the changes in the cellular uptake of the DMAs V . Additionally, as shown in Fig. 4 , we recently found that a unique biological effect of the DMAs V ; it directly stimulated the activity of a cysteine protease, papaine, in vitro, although other arsenics, including inorganic arsenite, arsenate and MMAs V , strongly inhibited this enzyme activity. It is possible that the DMAs V -induced apoptosis might be associated with the direct modulation of cysteine proteases because caspases known to regulate apoptosis are also cysteine proteases.
Thompson suggested in his previous review that GSH reduced DMAs V and that an unstable compound, such as dimethylarsinous acid (DMAs III ), might be formed, 19) 22, 23) Thus they suggest that the biomethylation of arsenics in mammals was not always a detoxification mechanism. However, under our experimental conditions shown there, DMAs Vinduced apoptosis in TRL 1215 cells might not be mediated via the formation of a toxic GSH-DMA complex, such as DMAs III -SG. The LC 50 of DMAs V in TRL 1215 cells, 1.5 mM, was much higher than that of DMAs III -SG which was estimated by Styblo et al., 1) and DMAs III -SG did not induce apoptosis under their experimental conditions. 1) We also observed that GSH actually could easily combine with DMAs V in phosphate buffered saline (PBS; pH = 7.4) using high performance thin layer chromatography. However, exogenous GSH (250 µM) slightly and significantly inhibited, but never enhanced, the
Fig. 4. Effects of Arsenic on the Cysteine Protease Activity in Vitro
Effects of arsenic on the cysteine protease activity were determined using EnzCheck™ Protease Kit (Molecular Probes, Co., Oregon, U.S.A.) and papain. 5 × 10 -4 U/ml papain was incubated with 10 mg/ml fluorescein conjugated casein in the presence or absence of 200 mM arsenic during 120 min, and fluoresent intensity was measured. Results are expressed as mean ± SEM (n = 3).
DMAs
V cytolethality regardless of the presence of BSO in the TRL 1215 cells (Table 1) . Also, as shown in Table 2 , exogenous GSH (250 µM) did not affect at all the cellular uptake of DMAs V . These data imply that exogenous µM levels of GSH might not be able to become cytotoxic together with DMAs V even though certain kinds of GSH-DMA complexes might be formed in the cell culture medium. Similar results were observed at every DMAs V /GSH ratios when µM levels of GSH were used, and the addition of other thiol reductants, such as L-cysteine and Nacethyl-L-cysteine, also showed similar effects with GSH. Ochi et al. reported that toxic trivalent dimethylarsine gas might be formed in the reaction between DMAs V and GSH in a cell culture medium. 24) We also examined if trivalent dimethylarsine gas was generated from the DMA-GSH mixture. Actually, a smelly gas was generated when purchased DMAs V was mixed with the same concentration of GSH in PBS, but most of this gas was trivalent trimethylarsine determined by gas chromatography-mass spectrometry. Thus, we reexamined using twice recrystallized DMAs V , and no gas was detected with GSH. GSH also did not generate any gas with MMAs V , but it generated trivalent trimethylarsine gas with TMAs V O. This strongly suggests that purchased DMAs V contains a small amount of TMAs V O as an impurity, and this impurity was reduced and converted to the smelly trimethylarsine gas with GSH. The degree of gasification of methyl arsenic compounds is dependent upon the number of methyls in the chemical structures. A higher reducing effect on methylated arsenics was observed from N-acethyl-L-cysteine than from GSH. Taken together, DMAs V may easily forms a soluble, non gas, complex with µM levels of GSH in the cell culture medium, but this complex may not be very cytotoxic. However, the cytolethality of mM levels of DMAs V was sometimes significantly enhanced by the addition of high concentrations, mM levels, of GSH at every DMAs V /GSH ratios. 5, 24) These findings indicate that high concentrations of DMAs V and/ or GSH might be needed to make these chemicals react and to keep the toxic unsuitable chemical form of the GSH-DMA complex, such as DMAs III -SG, in the cell culture medium because this complex might be rapidly oxidized in a normal cell culture medium, or it might be simple additive and/or synergistic cytotoxic effects between mM levels of DMAs V and GSH because GSH itself was also cytotoxic at mM levels like DMAs V ; its LC 50 in TRL 1215 cells was 12 mM and it alone showed a significant cytolethality from 10 mM. Further examinations are needed to verify the chemical characteristics and cytolethality of this putative GSH-DMA complex in the cell culture medium, however, a toxic GSH-DMA complex, DMAs III -SG, has not been detected yet in both human urine obtained from chronic arsenicosis patients 22, 23) and tissue samples from experimental animals which were injected with arsenic, 25) although only soluble dimehylarsinous acid (DMA III ) was detected from these samples. 22, 23, 25) Recent evidence suggests that soluble DMA III was strongly cytotoxic like inorganic arsenite in mammalian cells in vitro using synthetic iododimethlarsine (DMAs III I) as a source of this arsenic chemical, 1, 26, 27) and DMA III was actually detected from the animal tissue samples after the arsenic injection as a temporary intermediate of in vivo arsenic biomethylation. 25) Thus, as described above, it is suggested that arsenic biomethylation is not always the detoxification mechanism. However, some mammalian species, such as the marmoset monkey and the chimpanzee, have only a low resistance to arsenic because they have been shown not to be able to methylate the inorganic arsenic at all, 28) and serious clinical conditions of arsenic poisoning patients were sometimes observed in children because they have a lower degree of methylation of arsenic than adults in humans. 28) Suzuki et al. demonstrated using rat models that all of the injected inorganic arsenic was finally metabolitde to DMAs V , and excreted into the urine. 25) The in vitro cytolethality of DMAs V was much lower than that of inorganic arsenite as described in this review, and DMAs V selectively induced apoptosis via binding with intracellular GSH (Fig. 3) . DMAs V -induced apoptosis was observed in various species of mammalian cells, including human peripheral blood monocytes, human skin fibroblasts, chimpanzee skin fibroblasts, rat liver cells and mouse macrophages. 5, 12, 13) We also previously reported that DMAs V suppressed the release of inflammatory cytokines, such as tumor necrosis factorα and interleukin 1α, from mouse macrophages by induction of apoptosis, although inorganic arsenics induced a marked release of them in concert with necrosis. 5) Because apoptosis is a process by which organisms eliminate the damaged, precancerous or redundant cells without invoking an inflammatory responses, the biomethylation of inorganic arsenic in the human body may essentially be a detoxicating event by not only reducing its acute toxicity but also reducing the inflammatory potency.
